Cel-Sci Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$3.48

+0.27 (+8.41%)

As of Apr 1, 3:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 4 80%

Hold 1 20%

Sell 0 0%

Price Target

Analyst Price Target +1,205.2% upside

Low Target $30.66

Average Target $45.42

High Target $56.99

Current Price $3.48

Current
$3.48

Target
$45.42

$30.66 $45.42 avg $56.99

Scenario Analysis

Bear Case

$30.66

781.0%

Low target

Base Case

$45.42

+1,205.2%

Avg target

Bull Case

$56.99

+1,537.6%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$13.48

-74.2% from high

52-Week Low

$1.98

+75.8% from low

Target vs 52W High

$45.42

+237.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%